98%
921
2 minutes
20
Oncostatin M (OSM) and leukemia inhibitory factor (LIF) are pleiotropic cytokines from the interkeukine-6 family, associated with several disorders, and present significant potential in biomedicine. However, their therapeutic use is highly constrained by factors such as short circulating half-life and narrow therapeutic window. The conjugation of cytokines with elastin-like recombinamers (ELR) holds the potential to circumvent these limitations due to the ability of self-assembling upon a thermal stimulus, remarkable biocompatibility, and ease of processing. In this work, we report on the development of genetically engineered hybrid ELR conjugates by fusing the DNA sequences coding for murine/human OSM and LIF into the C-terminus of an ELR. The resulting hybrid fusion proteins demonstrated to retain the thermal properties of the ELR, which enabled the nonchromatographic purification by employing simple hot/cold cycles. Nanoparticles and free-standing films were obtained by self-assembly and solvent casting, respectively, using environmentally friendly processes (mild conditions and water-based methods). Both materials were characterized for their properties, revealing the absence of hemotoxicity upon contact with red blood cells and promising features for potential therapeutic applications. Overall, this work represents a step forward in the development of advanced functionalized biomaterials suitable for localized cytokine therapy.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11603303 | PMC |
http://dx.doi.org/10.1021/acsomega.3c09325 | DOI Listing |
ACS Appl Mater Interfaces
September 2025
Department of Biohybrid & Medical Textiles (BioTex), AME - Institute of Applied Medical Engineering, Helmholtz Institute, RWTH Aachen University, 52074 Aachen, Germany.
Medical devices such as vascular grafts, stents, and catheters are crucial for patient treatment but often suffer suboptimal integration with host tissues due to the nature of their surfaces. The materials commonly used, including metals and synthetic polymers, frequently lead to undesired immune responses and device failure. In this context, coating their surfaces with designer proteins has arisen as a promising strategy to improve the device's biointegration.
View Article and Find Full Text PDFInt J Biol Macromol
September 2025
G.I.R. Bioforge, University of Valladolid, CIBER-BBN, Paseo de Belén 19, Valladolid, Spain; Laboratory for Disruptive Interdisciplinary Science (LaDIS), University of Valladolid, 47011 Valladolid, Spain. Electronic address:
Cardiac tissues are difficult to regenerate due to the low proliferative capacity of cardiomyocytes. A new therapeutic strategy for cardiac regenerative medicine could include a device capable of ensuring cell grafting, stimulating cardiac tissue regeneration, and serving as an appropriate scaffold for the controlled and sustained release of lactate over time as an inducer of cardiomyocyte proliferation. An effective source of lactate could consist of the lactic acid polymer (PLA) itself, which generates free lactic acid during its degradation.
View Article and Find Full Text PDFJ Stomatol Oral Maxillofac Surg
July 2025
Centre for Oral, Clinical, and Translational Sciences, Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, London, UK.
Objectives: To examine the effectiveness of non-mineralised and pre-mineralised elastin-like recombinamer (ELR) membranes in guided bone regeneration (GBR) in a pre-clinical rabbit model.
Materials And Methods: Three pre-mineralised ELR membranes (D1, D2 and D8) and a non-mineralised (D0) membrane, along with a collagen membrane (C+) and an empty defect were randomly allocated in rabbit calvarial defects of critical size. Four weeks post-implantation the animals were euthanized and bone fill was assessed using micro CT and histological evaluation.
Adv Healthc Mater
June 2025
Department of Biohybrid and Medical Textiles (BioTex), AME-Institute of Applied Medical Engineering, Helmholtz Institute, RWTH Aachen University, 52074, Aachen, Germany.
Vascular grafts are crucial for treating cardiovascular diseases and providing vascular access for hemodialysis in end-stage renal disease, conditions that affect millions of people globally. To address the persisting clinical need for better therapy for these conditions, new designs involving novel materials and innovative tissue-engineered approaches are being developed. Successful clinical translation of such designs will require to ensure device safety, particularly sterility and mechanical integrity.
View Article and Find Full Text PDFJ Biomed Mater Res A
May 2025
i3S - Instituto de Investigação e Inovação Em Saúde, Universidade do Porto, Porto, Portugal.
With the degeneration of the intervertebral disc (IVD), the ingrowth of vascular and neural structures occurs. Both nerves and blood vessels engage in the development of inflammation and the onset of discogenic pain. The present study aimed to produce a hierarchical biomaterial capable of inhibiting angiogenesis by emulating the microenvironment of non-degenerated IVDs.
View Article and Find Full Text PDF